ASIA news
South Korean medical imaging AI company Neurophet has received second clearance for its brain image analysis software in the United States.
It obtained another 510(k) from the US Food and Drug Administration for the latest functionality on Neurophet Aqua that analyses multiple sclerosis and white matter hyperintensities using T2-FLAIR images.
The brain MRI scan-based analysis software, which...
Researchers from South Korea have built machine learning-based models that can predict mood episodes using only sleep and circadian rhythm data from wearable devices.
The team comprised researchers from the Institute for Basic Sciences (IBS), Korea Advanced Institute of Science and Technology (KAIST), and Korea University College of Medicine.
FINDINGS
In a study, which findings were published in...
Vuno receives second 510(k)
South Korean medical AI company Vuno has obtained a 510(k) clearance from the United States Food and Drug Administration for its chest X-ray analysis AI software.
The VunoMed Chest X-ray Triage quickly screens for pneumothorax and pleural effusion in chest X-ray images.
This FDA win is a second for Vuno, who first received a 510(k) for its brain image analysis AI in...
Singapore may be technologically advanced in healthcare, however, there may be sections in the health system that have yet to catch up – including sexual health.
In this small island nation-state of nearly six million people, sexual and reproductive health remains a topic too sensitive and intimate to be discussed in the open.
Access to the internet and the general acceptability of telemedicine...
A new company under financial investment firm SOL Partnership has launched what could be the first at-home gut health test service powered by AI in Malaysia.
SpaceGut offers an at-home gut microbiome kit and a laboratory service that provides personalised recommendations for an individual's gut health. Leveraging a proprietary AI, its laboratory evaluates samples compared against a database of...
Lunit collabs with AstraZeneca, secures major deal in France
Lunit and AstraZeneca have partnered to develop new AI-powered digital pathology solutions that predict non-small cell lung cancer (NSCLC).
Based on a media release, their collaboration aims to accelerate the time-consuming process of genomic testing as part of NSCLC identification and diagnosis by leveraging Lunit's AI. The latter's...
A consortium of research institutes in South Korea has been formed to promote the utilisation of AI and national supercomputers in discovering novel drugs for treating lung cancer.
According to a press statement, the following organisations will collaborate to develop and test AI for identifying novel drug candidates and predicting its efficacy:
DAAN Cancer Research Institute under Yonsei...
Neurophet sets up China JV
Medical imaging AI company Neurophet from South Korea has established a joint venture in China.
It recently signed an exclusive deal with LADO, one of the leading medical software providers in China, to market its AI-based software for quantifying levels of Alzheimer's disease biomarkers in PET images.
The deal, which also establishes a joint venture with LADO, aims...
South Korean medical AI company AITRICS has obtained clearance from the Ministry of Health, Vietnam for its AI software for predicting patient deterioration.
VitalCare utilises AI to analyse 19 types of EMR data of patients in general wards to predict possible death, ICU transfer, and cardiac arrest within six hours. It can also predict sepsis within four hours, cardiac arrest within 24 hours, as...
Collaborative research in Asia has called for prudence in using popular large language model-based (LLM) chatbots as part of public health research and response.
In a study, which findings were published in BMJ, researchers from the Chinese University of Hong Kong, RMIT University in Vietnam, and the National University of Singapore explored whether or not LLMs bridge or exacerbate the digital...
